January 26, 2024
“It’s a tough wager to make right now, after the electric-vehicle maker warned on Wednesday that it will expand at a “notably lower” pace this year, prompting a 12% plunge in the stock. It has now lost some $209 billion… Continue Reading…
March 11, 2021
“Orasure Technologies (OSUR)… A solid reputation in the field, and clear path forward are sure to attract positive sentiment – and three Wall Street analysts have put Buy ratings on Orasure, making the analyst consensus a Strong Buy. Shares are priced… Continue Reading…
January 20, 2021
“Datto Holding (MSP)… Hedberg represents the bullish view – Wall Street is somewhat more divided on this stock. There are 10 recent reviews, 5 to Buy and 5 to Hold, making the consensus rating a Moderate Buy. The average price target… Continue Reading…
December 31, 2020
“Matinas BioPharma (MTNB)… Turning now to the rest of the Street, other analysts echo Hazlett’s sentiment. As only Buy recommendations have been published in the last three months, MTNB earns a Strong Buy analyst consensus. With the average price target… Continue Reading…
December 23, 2020
“Palatin Technologies (PTN)… Overall, Palatin gets a Strong Buy rating from the analyst consensus, and that verdict is unanimous, based on 3 recent Buy reviews. The average price target, $2.17, implies an impressive 417% upside for the coming year… Mustang Bio… Continue Reading…
November 13, 2020
“Telephone & Data Systems… This stock also holds a Strong Buy rating from the analyst consensus, based on 3 unanimous Buy reviews set in recent weeks. Shares are priced at $18.73 and the average target of $34.83 suggests a one-year… Continue Reading…
November 9, 2020
“PulteGroup (PHM)… Overall, PulteGroup holds a Strong Buy rating from the analyst consensus, based on 6 Buys and 2 Hold set in recent weeks. The stock’s $43.12 trading price and $55.67 average price target imply a one-year upside of 22.5%… Dynatrace,… Continue Reading…
October 28, 2020
“Chromadex (CDXC)… It’s not often that the analysts all agree on a stock, so when it does happen, take note. CDXC’s Strong Buy consensus rating is based on a unanimous 3 Buys. The stock’s $7.67 average price target suggests a… Continue Reading…
September 30, 2020
“Seelos Therapeutics (SEEL)… Turning now to the rest of the Street, 2 Buys and no Holds or Sells have been published in the last three months. Therefore, SEEL has a Moderate Buy consensus rating. With the average price target clocking… Continue Reading…
September 30, 2020
“Brickell Biotech (BBI)… Looking at the consensus breakdown, 2 Buys and no Holds or Sells have been published in the last three months. As a result, BBI gets a Moderate Buy consensus rating. The $5 average price target is identical… Continue Reading…
Recent Comments